Experimental Agent Pins Elusive Primary Neuroendocrine Tumor

June 11, 2015

BALTIMORE, MD — An investigative radiotracer used to image neuroendocrine cancer patients who have metastatic tumors can successfully locate their previously elusive primary disease and change clinical management, according to a new study presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 Annual Meeting here.

"Many times patients first present with metastatic disease…and the primary site of metastatic neuroendocrine tumors (NETs) may go undetected in up to 20% of cases despite extensive work-up," said lead investigator Yusuf Menda, MD, associate professor of radiology and radiation oncology at the University of Iowa Carver College of Medicine in Iowa City.

Full Story